Using Game-based Exercise to Improve Balance in Cancer Patients



Status:Recruiting
Conditions:Cancer, Cancer, Neurology
Therapuetic Areas:Neurology, Oncology
Healthy:No
Age Range:55 - Any
Updated:7/14/2018
Start Date:May 2016
End Date:May 2019
Contact:Bijan Najafi, PhD
Email:bijan.najafi@bcm.edu
Phone:713-798-7536

Use our guide to learn which trials are right for you!

Managing Chemotherapy Induced Neuropathy in Cancer Patients Using Game-based Exercise

Cancer patients with chemotherapy-induced peripheral neuropathy (CIPN) have deficits in
sensory and motor skills leading to inappropriate proprioceptive feedback, impaired postural
control and high fall risk. This study will investigate the acceptability and effect of an
interactive motor adaptation balance training program based on wearable sensors for improving
balance in older cancer patients with CIPN. Cancer patients with confirmed CIPN will be
recruited and will be randomized to either intervention (IG) or control (CG) group and
followed for 6 months. The intervention group will take part in a 6-week balance training
program twice per week in either their home or in clinic (based on subject preference) under
the supervision of a qualified research staff member. This intervention includes interactive
game-based balance training including repetitive weight shifting and virtual obstacle
crossing tasks. Wearable sensors will provide real-time visual/auditory feedback from foot
and ankle position and allowed perception of motor-errors during each motor-action. The
control group will be instructed to complete a supervised foot and ankle exercise without
using sensor technology. Changes in balance, gait, and physical activity, and number of falls
will be compared pre- and post-intervention, as well as 3 and 6 month post intervention.
Investigators hypothesize that patients receiving sensor-based exercise training will benefit
more compared to group receiving conventional non-technology home-based training in terms of
improving functional performance and reducing falls.


Inclusion Criteria:

- Cancer patients

- Men or women aged 55 years or older

- Patients undergoing neurotoxic chemotherapy (agents including platinums, vinca
alkaloids, taxanes, proteasome inhibitors and interferons)

- Confirmed peripheral neuropathy (VPT>25) will be eligible to participate

Exclusion Criteria:

- Subjects will be excluded if they have undergone surgery in the last 6-8 weeks

- Have Parkinson's Disease

- Stroke patients

- Dementia patients

- Have an active foot ulcer

- Have an active infection

- Lower extremity major amputation

- Patient is taking medications unrelated to cancer treatment that may affect balance
and gait

- Patient has other medical conditions that may affect their balance and gait

- Patient is unable to ambulate without assistance.
We found this trial at
1
site
1200 Moursund Street
Houston, Texas 77030
(713) 798-4951
Phone: 713-798-7536
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
?
mi
from
Houston, TX
Click here to add this to my saved trials